James Renwick McCullough - Chief Executive Officer, Director at Renalytix plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
RNLX on Nasdaq, RTNXF on OTC
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Renwick McCullough since 7/7/2023

Holdings reported by James Renwick McCullough for Renalytix plc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Ordinary Shares 2,554,398 $639 K $0.25 Jul 1, 2023 By The McCullough 2020 Irrevocable Trust
Ordinary Shares 191,988 $48 K $0.25 Jul 1, 2023 Direct
Employee Stock Option (right to buy) 875,017 Jul 6, 2023 Direct Ordinary Shares

Transactions reported by James Renwick McCullough for Renalytix plc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership